Weiru Wang
Beijing University of Technology(CN)China State Shipbuilding (China)(CN)Frontier Aerospace Corporation (United States)(US)Frontier Medicines (United States)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Monoclonal and Polyclonal Antibodies Research, Chemokine receptors and signaling, Protein Kinase Regulation and GTPase Signaling, Biochemical and Molecular Research
Most-Cited Works
- → Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity(2008)1,340 cited
- → Diverse somatic mutation patterns and pathway alterations in human cancers(2010)1,025 cited
- → Recurrent R-spondin fusions in colon cancer(2012)969 cited
- → Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity(2012)623 cited
- → The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling(1999)468 cited
- → RAF inhibitors that evade paradoxical MAPK pathway activation(2015)376 cited
- →